Latest News for: ean
Edit
The Berkshire Eagle
27 Jun 2026
EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both ...
GENEVA, June 27, 2026 /PRNewswire/ -- Adults with both epilepsy and hearing loss who use hearing aids may have a 23% lower risk of developing dementia than those who do not, according to new research presented at the European Academy ....
Edit
The Indiana Times
27 Jun 2026
Johnson & Johnson presents new IMAAVY® (nipocalimab-aahu) data at European Academy of Neurology (EAN) 2026 ...
Edit
Hastings Tribune
27 Jun 2026
Monopar Presents New Analyses of Phase 3 FoCus Data at EAN 2026 Showing Greater Neurologic and
Edit
Morgan Citizen
27 Jun 2026
El uso de audífonos se asocia con riesgo de demencia 23 % menor en personas ...
Edit
Johnson & Johnson presents new IMAAVY® (nipocalimab-aahu) data at European Academy of Neurology (EAN) 2026 Congress reinforcing sustained disease control in generalized myasthenia gravis (Johnson & Johnson)
Public Technologies 26 Jun 2026
). The text version of this document is not available ... Attachments Permalink. Disclaimer.
Edit
The Daily Record - Dunn
26 Jun 2026
Monopar Presents New Analyses of Phase 3 FoCus Data at EAN 2026 Showing Greater Neurologic ...
Edit
Johnson & Johnson presents new IMAAVY®▼ (nipocalimab) data at European Academy of Neurology (EAN) 2026 ...
Nasdaq Globe Newswire 26 Jun 2026
Edit
EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
PR Newswire 26 Jun 2026
Edit
Monopar Presents New Analyses of Phase 3 FoCus Data at EAN 2026 Showing Greater Neurologic and Global Clinical Benefit with ALXN1840 Versus Standard of Care in Wilson Disease (Form 8-K) (Monopar Therapeutics Inc)
Public Technologies 26 Jun 2026
Edit
Monopar Presents New Analyses of Phase 3 FoCus Data at EAN 2026 Showing Greater Neurologic and Global Clinical Benefit with ALXN1840 Versus Standard of Care in Wilson Disease (Monopar Therapeutics Inc)
Public Technologies 26 Jun 2026
Edit
Johnson & Johnson presents new IMAAVY® (nipocalimab-aahu) data at European Academy of Neurology (EAN) 2026 Congress reinforcing sustained disease control in generalized myasthenia gravis
PR Newswire 26 Jun 2026
Edit
Angelini Pharma to organise a Satellite Symposium on epilepsy care at EAN 2026 (Aziende Chimiche Riunite Angelini Francesco SpA)
Public Technologies 24 Jun 2026
[...]. This is an abstract of the document. To keep reading, click here and get access to the original version ... Disclaimer.
Edit
Lundbeck presents new Vyepti® (eptinezumab) and bocunebart migraine portfolio data at EAN 2026
PR Newswire 24 Jun 2026
VALBY, Denmark, June 24, 2026 /PRNewswire/ -- H. Lundbeck A/S (Lundbeck) today announced that new migraine clinical data will be presented at the European Academy of Neurology (EAN) Congress 2026, taking place 27–30 June in Geneva, Switzerland.
Edit
Findings from Pivotal Multicenter Study Using SonoClear® System Acoustic Coupling Fluid Selected for Oral Presentation at European Association of Neurosurgical Societies (EANS) 2026 Annual Congress
PR Newswire 16 Jun 2026
I look forward to discussing the findings and their potential implications with the neurosurgical community at EANS," commented Dr.
Edit
Congratulations and Thank You, Class of 2026! – A message from President Berenecea Johnson Eanes (California State University, Los Angeles)
Public Technologies 21 May 2026
). So, who caught one of the tennis balls that Billie Jean King hit into the crowd during her Commencement ceremony?. That was truly one of the most joyful-and unique-moments I have experienced during all my years attending Commencement ... Disclaimer.
- 1
- 2
- Next page »